Contact us: +44 (0) 20 3033 3870

March Update: Pharma and Health

4 March 2019

What's on the agenda this month

by Philippa Keir, Health Policy Executive

NHS Long Term Plan

As we enter March, the month that the UK is scheduled to leave the EU, it appears to be one filled with an abundance of legislation passing through both Houses at unprecedented speed.

We are expecting to see some very important Bills reach the remaining stages of the legislative process, with the Mental Capacity (Amendment) Bill currently in the consideration of amendments stage, and the Organ Donation (Deemed Consent) Bill expected to reach this stage any day now. The Healthcare (International Arrangements) Bill is also scheduled to have its report stage on 12th March, only 17 days ahead of the UK’s official Exit Day.

Alongside the fast processing of these Bills, a significant number of Statutory Instruments are also flooding through the legislative process this month. Fourteen health and social care SIs have been scheduled to be considered this week, with the purpose of instating the legislative foundations of the Withdrawal Agreement, which are still yet to be accepted by the House of Commons.

Support your strategic planning with DeHavilland

DeHavilland can help with your forward planning, by giving you early warning of the key events impacting your sector.

Contact us for a free consultation today to find out how we can help you manage risks and identify opportunities.

 
Philippa Keir, Health Policy Executive
Philippa Keir
Health Policy Executive

Philippa Keir is DeHavilland's policy specialist for Health. She previously worked for a public affairs consultancy, and read History and Politics at the University of Exeter.